N-([1,1'-Biphenyl]-2-yl)-2-((4-allyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

Catalog No. :
ACLCDE637
CAS No. :
573935-42-9
Molecular Formula :
C23H20N4OS2
Molecular Weight :
432.57

IUPAC Name:N-([1,1'-biphenyl]-2-yl)-2-((4-allyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

N-([1,1'-Biphenyl]-2-yl)-2-((4-allyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-([1,1'-Biphenyl]-2-yl)-2-((4-allyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
IUPAC NameN-([1,1'-biphenyl]-2-yl)-2-((4-allyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
MDL No.MFCD04020018
Molecular FormulaC23H20N4OS2
Molecular Weight432.57
SMILESO=C(NC1=CC=CC=C1C2=CC=CC=C2)CSC3=NN=C(C4=CC=CS4)N3CC=C
InChI KeyFSPOZUNJIDPRPK-UHFFFAOYSA-N
SynonymSALOR-INT L414247-1EA;2-([4-ALLYL-5-(2-THIENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-[1,1'-BIPHENYL]-2-YLACETAMIDE;Acetamide, N-[1,1'-biphenyl]-2-yl-2-[[4-(2-propen-1-yl)-5-(2-thienyl)-4H-1,2,4-triazol-3-yl]thio]-;2-{[4-ALLYL-5-(2-THIENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N-[1,1'-BIPHENYL]-2-YLACETAMIDE
CAS No.573935-42-9

Synthetic Route by SureRoute

1. ACLCDE637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJZYR508 route compound structure diagram
    ACJZYR5082185-92-4 In Stock
  4. Then
  5. ACLCDE637 route product structure diagram
    ACLCDE637573935-42-9
Inquiry

2. ACLCDE637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLCDE637 route product structure diagram
    ACLCDE637573935-42-9
Inquiry

Comments (0)